TIL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TIL, covering 2023-12-12 to 2023-12-12. Get the full timeline:
Most recent: Clinical Trial Update: TIL and Anti-PD1 in Metastatic Melanoma [Phase 1, Phase 2]